Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 11, 2024

SELL
$235.51 - $267.98 $116,106 - $132,114
-493 Reduced 34.4%
940 $234,000
Q1 2024

Apr 24, 2024

BUY
$224.58 - $256.19 $3,368 - $3,842
15 Added 1.06%
1,433 $357,000
Q4 2023

Mar 28, 2024

SELL
$185.1 - $233.13 $100,879 - $127,055
-545 Reduced 27.76%
1,418 $328,000
Q3 2023

Oct 17, 2023

SELL
$233.08 - $265.59 $30,766 - $35,057
-132 Reduced 6.3%
1,963 $487,000
Q2 2023

Jul 21, 2023

SELL
$224.99 - $256.14 $85,946 - $97,845
-382 Reduced 15.42%
2,095 $502,000
Q1 2023

Apr 18, 2023

SELL
$239.75 - $277.0 $11,508 - $13,296
-48 Reduced 1.9%
2,477 $624,000
Q4 2022

Jan 17, 2023

SELL
$241.42 - $282.29 $33,315 - $38,956
-138 Reduced 5.18%
2,525 $0
Q3 2022

Oct 13, 2022

SELL
$247.06 - $1507.4 $18,282 - $111,547
-74 Reduced 2.7%
2,663 $688,000
Q2 2022

Jul 15, 2022

SELL
$237.11 - $299.66 $41,968 - $53,039
-177 Reduced 6.07%
2,737 $694,000
Q1 2022

Apr 26, 2022

SELL
$257.27 - $315.76 $411,632 - $505,216
-1,600 Reduced 35.45%
2,914 $855,000
Q4 2021

Jan 19, 2022

BUY
$292.08 - $329.01 $98,138 - $110,547
336 Added 8.04%
4,514 $1.49 Million
Q3 2021

Oct 27, 2021

BUY
$272.21 - $332.43 $354,417 - $432,823
1,302 Added 45.27%
4,178 $1.27 Million
Q2 2021

Sep 07, 2021

BUY
$225.08 - $271.69 $187,716 - $226,589
834 Added 40.84%
2,876 $772,000
Q1 2021

Sep 07, 2021

BUY
$212.38 - $245.9 $27,821 - $32,212
131 Added 6.86%
2,042 $460,000
Q4 2020

Sep 07, 2021

SELL
$212.5 - $245.46 $92,650 - $107,020
-436 Reduced 18.58%
1,911 $425,000
Q3 2020

Sep 07, 2021

BUY
$177.16 - $215.33 $415,794 - $505,379
2,347 New
2,347 $505,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.